Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
Docusign reported solid growth and stronger profitability for its fourth quarter and fiscal 2026 while significantly expanding its share repurchase capacity. Fourth-quarter revenue was $836.9 million, up 8% year over year, with subscription revenue of $819.0 million also up 8%. Billings reached $1.0 billion, a 10% increase, and GAAP gross margin edged up to 79.7%. GAAP diluted EPS was $0.44, while non-GAAP diluted EPS rose to $1.01. Free cash flow improved to $350.2 million from $279.6 million.
For fiscal 2026, revenue was $3.2 billion, up 8%, and billings were $3.4 billion, up 10%. Annual Recurring Revenue was $3,272 million, an 8% increase, with Intelligent Agreement Management contributing over $350 million in ARR and 10.8% of total ARR, up from 2.3% a year earlier. Non-GAAP diluted EPS grew to $3.84.
Docusign’s board authorized an additional $2.0 billion for its stock repurchase program, bringing remaining authorization to up to $2.6 billion. Guidance for fiscal 2027 calls for revenue of $3.484–$3.496 billion, roughly 8% growth, with targeted non-GAAP operating margins of 30.0–30.5%.
Docusign, Inc. reported that its Board of Directors appointed Brian Roberts to fill an existing vacancy on the Board, effective March 5, 2026. He will serve as a Class I director with a term running until the company’s 2028 Annual Meeting of Stockholders.
The Board determined that Brian Roberts qualifies as an independent director under securities laws and Nasdaq listing standards. The company states there is no arrangement with any other person regarding his selection and no material related-party transactions involving him. He will be compensated under Docusign’s existing director compensation program and has entered into the company’s standard indemnity agreement.
DOCUSIGN, INC. director Anna Marrs reported a mix of stock-based transactions. On March 5, 2026, she completed an open-market sale of 363 shares of common stock at $46.33 per share, leaving her with 12,251 common shares held directly.
On March 4, 2026, she exercised 725 restricted stock units (RSUs), converting them into an equal number of common shares at $0.00 per share. Each RSU represents a right to receive one share of common stock and vests in twelve equal quarterly installments over three years starting on June 4, 2023, subject to continued service. The filing notes the sale was made under a pre-arranged Rule 10b5-1 trading plan.
Anna Marrs submitted a Form 144 notice to sell restricted common stock. The filing lists 363 restricted shares to be sold through Morgan Stanley Smith Barney LLC with a sale date of 03/04/2026. The form also reports a prior sale of 365 common shares on 03/03/2026 with proceeds shown as 16432.30.
DOCUSIGN, INC. director Enrique T. Salem reported an automatic conversion of equity awards rather than an open-market trade. On February 28, 2026, he exercised 729 Restricted Stock Units (RSUs), which converted into 729 shares of common stock at a price of $0.00 per share. After this conversion, his directly held common stock position rose to 166,589 shares.
Each RSU represents the right to receive one share of common stock. The underlying RSU grant has a vest commencement date of May 29, 2025 and vests in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service. The RSUs themselves do not expire.
DocuSign director Teresa Briggs reported the conversion of restricted stock units into common shares. On the reported date, 729 Restricted Stock Units were exercised at a stated price of $0.0000 per unit, resulting in 729 shares of common stock. After this derivative exercise and corresponding acquisition, she directly owned 9,899 shares of DocuSign common stock. Each RSU represents a right to receive one share and, per the disclosure, RSUs vest in equal quarterly installments over one year from a vest commencement date of May 29, 2025, provided she remains a service provider through each vesting date.
DocuSign, Inc. director Irving Blake reported acquiring shares through an equity award. On February 28, 2026, 729 Restricted Stock Units were exercised or converted into 729 shares of common stock at a stated price of $0.00 per share, bringing his direct common stock holdings to 25,364 shares.
Each RSU represents a right to receive one share of common stock. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, subject to continued service. The RSUs do not expire and will either vest or be canceled before the vesting date.
DocuSign director Peter Solvik reported an equity award transaction involving restricted stock units. On February 28, 2026, he exercised 729 Restricted Stock Units, which converted into 729 shares of DocuSign common stock at a stated price of $0.00 per share.
After this conversion, Solvik directly held 8,241 shares of common stock. The filing also notes indirect holdings as of that date, including 120,253 shares by a trust, 65,558 shares by children's trusts, 3 shares by a family partnership, and 6,458 shares by his spouse. Each RSU represents a right to receive one share and vests in quarterly installments over one year starting May 29, 2025.
DOCUSIGN, INC. director Mary Agnes Wilderotter acquired 729 shares of common stock through the exercise and conversion of Restricted Stock Units on February 28, 2026 at a price of $0.00 per share. Following this transaction, she directly holds 59,803 common shares.
Each RSU represents a right to receive one share of common stock. These RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to her continued service. The RSUs do not expire; they either vest or are canceled before vesting.
DocuSign director James A. Beer reported mixed insider activity. On March 3, 2026, he sold 450 shares of common stock in an open-market trade at $45.02 per share under a pre-arranged Rule 10b5-1 plan. On February 28, 2026, he acquired 729 shares of common stock from the conversion of 729 Restricted Stock Units. Following these transactions, he directly held 14,757 common shares, with an additional 5,543 shares held indirectly by a trust.